A Safety Study of LY3372689 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
- Status
- RECRUITING
- Phase
- PHASE3
Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
A Study of Baricitinib in Participants With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3471851 in Participants With Eczema
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Lasmiditan in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3475766 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY900014 in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY900020 in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1
Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)
- Status
- RECRUITING
- Phase
- PHASE2